![]() |
市場調查報告書
商品編碼
1873564
共軛亞麻油酸 (CLA) - 全球市場佔有率和排名、總收入和需求預測(2025-2031 年)Conjugated Linoleic Acid (CLA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024 年全球共軛亞麻油酸 (CLA) 市場規模估計為 5,720 萬美元,預計到 2031 年將達到 8,810 萬美元,在預測期(2025-2031 年)內複合年成長率為 6.5%。
本報告對近期關稅調整和國際對共軛亞麻油酸 (CLA) 採取的戰略反制措施的跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組進行了全面評估。
共軛亞麻油酸 (CLA) 是亞麻油酸位置異構體和幾何異構體的統稱。亞麻油酸是一種多效價Omega-6脂肪酸,天然存在於牛等反芻動物的肉類和乳製品中。 CLA 的特徵在於其共軛雙鍵。具體而言,它有兩個雙鍵,由一個碳單鍵連接,而不是多不飽和脂肪酸中常見的亞甲基間接鍵。生物活性最強且研究最廣泛的異構體是順式-9、反式-11 CLA(反芻亞麻油酸)和反式-10、順式-12 CLA。這些異構體與多種生理和健康益處有關,並且是全球對 CLA 基產品需求的主要驅動力。
共軛亞麻油酸 (CLA) 主要來自兩個方面:天然來源和商業性合成。天然 CLA 存在於草飼動物的肉類和乳製品中,但含量極低。然而,市售 CLA 補充劑通常是透過化學或酵素法異構化植物油(例如紅花油、葵花籽油和大豆油)中的亞麻油酸而製成的。市售 CLA 產品通常是兩種主要異構體各佔 50% 的混合物。這些產品有多種形式,包括軟膠囊、粉末和機能性食品配料。
由於科學報告顯示共軛亞麻油酸(CLA)具有減少體脂、增加肌肉量、提高代謝率、改善免疫功能以及發揮抗癌、抗糖尿病和抗動脈粥樣硬化作用等潛在功效,CLA在膳食補充劑和功能機能性食品食品領域備受關注。這些發現使CLA成為體重管理產品、運動營養品和一般保健品中的一種重要成分,吸引了從運動員到注重健康的老年人等廣泛的消費者群體。
CLA市場可細分為膳食補充劑、功能性食品和飲料、動物飼料以及藥品。其中,膳食補充劑佔市場主導地位,佔有率最大。 CLA補充劑通常宣稱具有促進脂肪燃燒、提高運動表現和維護代謝健康等功效,並且在保健食品店、藥店、線上平台和超級市場均有銷售。
CLA 在功能性食品和飲料中的應用正在蓬勃發展,製造商將其添加到強化乳製品、蛋白質棒和代餐等產品中,主要目標客戶是希望控制體重和改善身體成分,而無需依賴藥物或極端飲食限制的消費者。
畜牧飼料產業也是一個重要且不斷成長的領域。飼料中添加共軛亞麻油酸(CLA)可以提高肉類和乳製品的營養價值,增加CLA含量,而CLA被認為有益於人體健康。這與消費者日益成長的對天然強化「潔淨標示」食品的偏好相符。
儘管共軛亞麻油酸(CLA)的藥用價值仍相對有限,但已展現出一定的潛力。對其抗發炎、抗癌和胰島素增敏特性的研究有望為治療製劑的開發開闢新的途徑。然而,CLA的藥用價值仍受限於需要進行更多確鑿的臨床試驗、獲得監管部門的核准以及成本方面的考慮。
全球主要企業包括BASF(BASF)、英諾博 (INNOBIO) 和斯蒂潘 (Stepan)(脂質營養公司)。前三大企業佔了約 65% 的市場。北美市佔率最大,約 40%,其次是歐洲和亞太地區,分別佔 30% 和 20%。
本報告旨在對全球共軛亞麻油酸 (CLA) 市場按地區/國家、含量和應用進行全面分析,重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。
本報告以銷售量(噸)和收入(百萬美元)為單位,對共軛亞麻油酸(CLA)市場規模、估算和預測進行了闡述,以2024年為基準年,並涵蓋了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法,幫助讀者制定業務/成長策略,評估市場競爭格局,分析自身在當前市場中的地位,並就共軛亞麻油酸(CLA)做出明智的商業決策。
市場區隔
公司
按內容細分
應用領域
按地區
The global market for Conjugated Linoleic Acid (CLA) was estimated to be worth US$ 57.2 million in 2024 and is forecast to a readjusted size of US$ 88.1 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Conjugated Linoleic Acid (CLA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Conjugated Linoleic Acid (CLA) refers to a group of positional and geometric isomers of linoleic acid, a polyunsaturated omega-6 fatty acid that naturally occurs in meat and dairy products derived from ruminant animals such as cows and sheep. CLA is characterized by its conjugated double bonds - specifically, the presence of two double bonds separated by a single carbon bond, rather than the typical methylene interruption seen in most polyunsaturated fatty acids. The most biologically active and extensively studied isomers are cis-9, trans-11 CLA (rumenic acid) and trans-10, cis-12 CLA. These isomers are associated with a variety of physiological effects and health benefits, which have been the primary drivers behind the global demand for CLA-based products.
CLA is primarily obtained from two sources: natural sources and commercial synthesis. Natural CLA is found in trace amounts in meat and dairy products of grass-fed animals. However, commercial CLA supplements are generally produced by chemical or enzymatic isomerization of linoleic acid derived from vegetable oils such as safflower, sunflower, or soybean oils. The commercially available CLA products typically consist of a 50:50 mixture of the two main isomers. These products are offered in a variety of forms, including softgel capsules, powders, and functional food ingredients.
CLA gained prominence in the dietary supplement and functional food sectors due to scientific reports suggesting its potential roles in reducing body fat mass, increasing lean muscle mass, enhancing metabolic rate, improving immune function, and exerting anticancer, antidiabetic, and antiatherogenic properties. These findings have positioned CLA as a valuable ingredient in weight management products, sports nutrition, and general health supplements, attracting a broad consumer base ranging from athletes to health-conscious individuals and aging populations.
The CLA market is segmented by end-use application into dietary supplements, functional foods & beverages, animal feed, and pharmaceuticals. Among these, dietary supplements dominate the market, accounting for the largest share. CLA supplements are frequently marketed for their purported abilities to promote fat loss, enhance athletic performance, and support metabolic health. They are widely sold through health stores, pharmacies, online platforms, and supermarkets.
Functional food and beverage applications of CLA are gaining momentum, with manufacturers incorporating CLA into products such as fortified dairy items, protein bars, and meal replacements. These functional food applications are often targeted at consumers looking to manage weight or improve body composition without resorting to pharmaceuticals or extreme dieting.
Animal feed, particularly for livestock, is another important and growing segment. CLA-enriched feed is used to enhance the nutritional quality of meat and dairy products by increasing their CLA content, which is considered beneficial for human health. This aligns with the rising consumer preference for naturally fortified, "clean label" foods.
Pharmaceutical applications remain relatively limited but promising. Research into the anti-inflammatory, anticancer, and insulin-sensitizing properties of CLA could open new opportunities in the formulation of therapeutic products. However, pharmaceutical use is constrained by the need for more definitive clinical trials, regulatory approvals, and cost considerations.
Global key players of Conjugated Linoleic Acid (CLA) include BASF, INNOBIO, Stepan (Lipid Nutrition), etc. The top three players hold a share about 65%. North America is the largest market, and has a share about 40%, followed by Europe and Asia-Pacific with share 30% and 20%, separately.
This report aims to provide a comprehensive presentation of the global market for Conjugated Linoleic Acid (CLA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Conjugated Linoleic Acid (CLA) by region & country, by Content, and by Application.
The Conjugated Linoleic Acid (CLA) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugated Linoleic Acid (CLA).
Market Segmentation
By Company
Segment by Content
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conjugated Linoleic Acid (CLA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Content, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Conjugated Linoleic Acid (CLA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Conjugated Linoleic Acid (CLA) in country level. It provides sigmate data by Content, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.